Scotts Miracle-Gro（0L45）株式概要スコッツ・ミラクル・グロー・カンパニーは、その子会社とともに、米国内外で芝生、庭の手入れ、屋内および水耕栽培用の製品の製造、マーケティング、販売に従事している。 詳細0L45 ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長1/6過去の実績4/6財務の健全性2/6配当金5/6報酬当社が推定した公正価値より18.6%で取引されている 収益は年間10.58%増加すると予測されています 過去1年間で収益は389.5%増加しました 4.18%の安定した配当金を支払う リスク分析多額の負債を抱えている すべてのリスクチェックを見る0L45 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$63.7047.5% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-612m5b2016201920222025202620282031Revenue US$3.7bEarnings US$218.2mAdvancedSet Fair ValueView all narrativesThe Scotts Miracle-Gro Company 競合他社Croda InternationalSymbol: LSE:CRDAMarket cap: UK£4.2bMondiSymbol: LSE:MNDIMarket cap: UK£3.2bHill & SmithSymbol: LSE:HILSMarket cap: UK£2.2bElementisSymbol: LSE:ELMMarket cap: UK£889.8m価格と性能株価の高値、安値、推移の概要Scotts Miracle-Gro過去の株価現在の株価US$63.7052週高値US$72.4752週安値US$51.99ベータ1.831ヶ月の変化11.27%3ヶ月変化1.43%1年変化2.99%3年間の変化0.96%5年間の変化-67.26%IPOからの変化-41.01%最新ニュースBuy Or Sell Opportunity • May 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to US$58.93. The fair value is estimated to be US$74.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Upcoming Dividend • May 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 May 2026. Payment date: 05 June 2026. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (3.9%).Buy Or Sell Opportunity • May 10Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to US$61.67. The fair value is estimated to be US$77.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.お知らせ • May 01the Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal 2026. For the period, the company re-affirmed U.S. Consumer net sales low single-digit growth.Reported Earnings • Apr 30Second quarter 2026 earnings released: EPS: US$4.53 (vs US$3.78 in 2Q 2025)Second quarter 2026 results: EPS: US$4.53 (up from US$3.78 in 2Q 2025). Revenue: US$1.46b (up 2.7% from 2Q 2025). Net income: US$263.3m (up 21% from 2Q 2025). Profit margin: 18% (up from 15% in 2Q 2025). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 7.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.New Risk • Apr 30New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Earnings have declined by 26% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (93% payout ratio). Large one-off items impacting financial results.最新情報をもっと見るRecent updatesBuy Or Sell Opportunity • May 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to US$58.93. The fair value is estimated to be US$74.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Upcoming Dividend • May 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 May 2026. Payment date: 05 June 2026. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (3.9%).Buy Or Sell Opportunity • May 10Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to US$61.67. The fair value is estimated to be US$77.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.お知らせ • May 01the Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal 2026. For the period, the company re-affirmed U.S. Consumer net sales low single-digit growth.Reported Earnings • Apr 30Second quarter 2026 earnings released: EPS: US$4.53 (vs US$3.78 in 2Q 2025)Second quarter 2026 results: EPS: US$4.53 (up from US$3.78 in 2Q 2025). Revenue: US$1.46b (up 2.7% from 2Q 2025). Net income: US$263.3m (up 21% from 2Q 2025). Profit margin: 18% (up from 15% in 2Q 2025). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 7.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.New Risk • Apr 30New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Earnings have declined by 26% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (93% payout ratio). Large one-off items impacting financial results.Declared Dividend • Apr 26First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd May 2026 Payment date: 5th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is well covered by cash flows (43% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 81% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Apr 23The Scotts Miracle-Gro Company to Report Q2, 2026 Results on Apr 29, 2026The Scotts Miracle-Gro Company announced that they will report Q2, 2026 results Pre-Market on Apr 29, 2026お知らせ • Apr 21The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on June 5, 2026The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a quarterly cash dividend of $0.66 per share. The dividend is payable on June 5, 2026, to shareholders of record as of May 22, 2026.Buy Or Sell Opportunity • Mar 27Now 25% undervaluedOver the last 90 days, the stock has risen 4.5% to US$61.69. The fair value is estimated to be US$81.85, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.6% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 0.6% in 2 years. Earnings are forecast to grow by 74% in the next 2 years.お知らせ • Mar 18ScottsMiracle-Gro, Bonnie Plants And Gardenuity Launches Inspired To Gro Patio Garden CollectionScottsMiracle-Gro, Bonnie Plants and Gardenuity announced the launch of the Inspired to Gro Patio Garden Collection, a fully integrated gardening experience designed to help new and emerging gardeners grow successfully from day one. Inspired to Gro combines ScottsMiracle-Gro’s plant nutrients, Bonnie Plants’ fully rooted starter plants and Gardenuity’s guided gardening platform – including its curated container garden design, integrated growing components and personalized guidance platform – into a single product offering. This strategic collaboration between three leaders in the lawn and garden industry aims to remove the barriers that have historically prevented millions of interested consumers from starting and sustaining a garden. Inspired to Gro delivers everything needed to plant, grow and thrive in one seamless experience. While millions of Americans express interest in gardening, many struggle with where to begin or how to maintain success over time. Inspired to Gro addresses the barriers. Gardenuity was founded on the belief that gardening should be accessible to everyone, regardless of experience or space. Inspired to Gro removes the uncertainty that keeps so many people from starting by giving them the tools, plants and guided support they need to grow successfully from day one. The launch comes as consumers increasingly prioritize wellness, sustainability and fresh food access, fueling renewed interest in home gardening. Bonnie Plants, which has supplied vegetable and herb plants to American gardeners for more than a century, sees the collaboration as an important step in expanding access to gardening. For more than 100 years, Bonnie Plants has helped people grow their own food at home. Inspired to Gro builds on that legacy by making gardening more approachable and successful for more people. The collection features thoughtfully curated plant selections to support wellness, nourishment and enjoyment. The Inspired to Gro Patio Garden Collection includes three distinct offerings — Everyday Good Seasonal Herb Garden, Well Bloomed Limited Edition Edible Flower and Seasonal Herb Garden and Simply Rooted Seasonal Vegetable and Herb Garden. Inspired to Gro is now available on Amazon, Bonnieplants.com and Gardenuity.com with plans to expand to other ecommerce sites. Each Inspired to Gro garden includes: Gardenuity’s signature 5-gallon, double-stitched grow bag with reinforced handles for optimal root health and durability. Custom-blended soil, formulated specifically for container growing success. Four fully rooted Bonnie Plants selected and aligned to the consumer’s location and seasonal growing conditions. Miracle-Gro Pour & Feed Plant Food to provide essential nutrients to support plant growth and vitality. Grow Pro support from Gardenuity, including personalized guidance and weather-based garden notifications to help ensure ongoing success.Upcoming Dividend • Feb 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 20 February 2026. Payment date: 06 March 2026. Payout ratio is on the higher end at 93%, however this is supported by cash flows. Trailing yield: 3.9%. Lower than top quartile of British dividend payers (5.3%). Higher than average of industry peers (3.5%).お知らせ • Feb 04Miracle-Gro Introduces Refreshed Lineup of Their Indoor Soils and Plant FoodsMiracle-Gro introduced a refreshed lineup of their indoor soils and plant foods. In addition, they are launching new plant care solutions, plus a brand new organic plant food item designed to make indoor gardening an approachable form of self-care, helping people nurture their homes while supporting their well-being. Research shows Americans are nearly twice as likely to report a decline in mood during the winter months (41%) than an improvement (22%). Indoor gardening offers a calming, screen-free way to restore routine, confidence and a sense of progress rooted in care and growth. With simple, intuitive solutions, Miracle-Gro's refreshed indoor assortment removes the guesswork from plant care, making it easy for anyone - from first-time plant parents to seasoned growers - to build a wellness habit that fits seamlessly into everyday life. The updated lineup features over 10 best-selling Miracle-Gro indoor products with clearer, easier-to-shop packaging, designed to reduce decision fatigue and help shoppers quickly find the right solution for their plants. In addition, two new plant care solutions designed to combat pesky insects while beautifying plants, and one new easy-to-use organic plant food solution. Highlights from the refreshed indoor portfolio & new items include: Miracle-Gro Indoor Potting Mixes: Tailored mixes for All Plants, Cactus & Succulent, Tropicals, Orchids and Seed Starting support healthier growth with less guesswork. Miracle-Gro Indoor Plant Foods: Easy-to-use liquid plant foods deliver essential nutrients for stronger, healthier indoor plants. The variety includes All Plants, Cactus &Succulent, Tropicals,Orchids and Plant Food Spikes for All Plants. Miracle-Gro Organic Indoor Plant Food: Made from 94% plant based fertilizer ingredients, this new organic plant food provides instant nourishment for healthier, more resilient plants (vs unfed plants when used as directed). Miracle-Gro Plant Care Flying insect Traps: A sleek, double-sided leaf shaped design that blends seamlessly into plants while quietly capturing flying insects before they can damage roots - protecting both plants and peace of mind. Miracle-Gro Plant Care Leaf Protect & Shine: Gentle on plants and tough on pests, this solution helps protect against common houseplant issues, while beautifying natural leaf shine. Products range from $4.97 - $17.99 and are available at scottsmiraclegro.com and select national retailers, including Amazon, Home Depot, Target and Walmart. Availability may vary by product and retailer. For specific tips and tricks on indoor gardening, you can visit the Miracle-Gro website for helpful blog posts.Declared Dividend • Feb 01First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 20th February 2026 Payment date: 6th March 2026 Dividend yield will be 4.1%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 67% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Jan 29The Scotts Miracle-Gro Company (NYSE:SMG) announces an Equity Buyback for $500 million worth of its shares.The Scotts Miracle-Gro Company (NYSE:SMG) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its shares. The repurchase program has no time limit.Reported Earnings • Jan 29First quarter 2026 earnings released: US$0.83 loss per share (vs US$1.21 loss in 1Q 2025)First quarter 2026 results: US$0.83 loss per share (improved from US$1.21 loss in 1Q 2025). Revenue: US$354.4m (down 15% from 1Q 2025). Net loss: US$47.8m (loss narrowed 31% from 1Q 2025). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Jan 28The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal Year 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal year 2026. For the year, the company expects U.S. Consumer net sales low single-digit growth.お知らせ • Jan 27The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on March 6, 2026The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 6, 2026, to shareholders of record as of February 20, 2026.お知らせ • Jan 20The Scotts Miracle-Gro Company to Report Q1, 2026 Results on Jan 28, 2026The Scotts Miracle-Gro Company announced that they will report Q1, 2026 results at 9:00 AM, Eastern Standard Time on Jan 28, 2026お知らせ • Dec 18The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026.Declared Dividend • Nov 09Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 21st November 2025 Payment date: 5th December 2025 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (105% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 16% to bring the payout ratio under control. EPS is expected to grow by 62% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • Nov 06Full year 2025 earnings released: EPS: US$2.52 (vs US$0.61 loss in FY 2024)Full year 2025 results: EPS: US$2.52 (up from US$0.61 loss in FY 2024). Revenue: US$3.41b (down 3.9% from FY 2024). Net income: US$145.2m (up US$180.1m from FY 2024). Profit margin: 4.3% (up from net loss in FY 2024). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Nov 06+ 1 more updateThe Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on December 5, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on December 5, 2025, to shareholders of record as of November 21, 2025.お知らせ • Oct 23The Scotts Miracle-Gro Company to Report Q4, 2025 Results on Nov 05, 2025The Scotts Miracle-Gro Company announced that they will report Q4, 2025 results Pre-Market on Nov 05, 2025Board Change • Sep 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Austin Miller was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Aug 18Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 August 2025. Payment date: 05 September 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Lower than top quartile of British dividend payers (5.5%). In line with average of industry peers (4.3%).お知らせ • Aug 06The Scotts Miracle-Gro Company Announces Changes to Board of DirectorsThe Scotts Miracle-Gro Company announced changes to its Board of Directors. Former U.S. Army Lt. General John R. Vines announced his retirement after more than 12 years on the Board, most recently as a member of the Nominating & Governance and Innovation & Technology committees. His term was set to expire at the 2027 annual meeting of shareholders. Although he no longer is a member of the Board, he will maintain an advisory role as Board member emeritus. Vines served 35 years in the military, commanding the U.S. Army’s XVII Airborne Corps and 27-nation Multi-National Corps in Iraq and the Combined Joint Task Force and 82nd Airborne Division in Afghanistan. Replacing Vines is retired U.S. Army General Scott Miller, who commanded at all grades, most notably as commanding general of the U.S. Army Maneuver Center at Fort Benning and as commander of the Joint Special Operations Command, where he directed U.S. operations in complex geopolitical regions including the Indo-Pacific, Africa, Middle East and South Asia. He also commanded assault forces in Mogadishu, Somalia, during “Blackhawk Down.” His numerous decorations and honors include two awards of the coveted Combat Infantryman Badge, two Purple Hearts, the Silver Star and an unprecedented 20 Overseas Service Bars denoting more than 10 full years in combat zones. In 2023, he was selected as a distinguished graduate of the United States Military Academy and the recipient of the Richard M. Helms Award presented by the CIA Memorial Foundation. In retirement, Miller has pursued an understanding of business serving in both leadership roles and board positions. Through the Miller Advisory Group he consults overseas, speaks on world topics and hosts leadership retreats. He is a senior fellow for the Combating Terrorism Center at the U.S. Military Academy, where he mentors future leaders, and is an ambassador for the nonprofit Shields and Stripes, which is focused on veterans and first responders.Declared Dividend • Aug 04Third quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd August 2025 Payment date: 5th September 2025 Dividend yield will be 4.3%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (285% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 217% to bring the payout ratio under control. EPS is expected to grow by 116% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.Reported Earnings • Aug 01Third quarter 2025 earnings released: EPS: US$2.58 (vs US$2.33 in 3Q 2024)Third quarter 2025 results: EPS: US$2.58 (up from US$2.33 in 3Q 2024). Revenue: US$1.19b (down 1.2% from 3Q 2024). Net income: US$149.1m (up 13% from 3Q 2024). Profit margin: 13% (up from 11% in 3Q 2024). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.お知らせ • Jul 30+ 1 more updateThe Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Full Year Fiscal 2025The Scotts Miracle-Gro Company reaffirmed earnings guidance for the full year fiscal 2025. U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales).お知らせ • Jul 17The Scotts Miracle-Gro Company to Report Q3, 2025 Results on Jul 30, 2025The Scotts Miracle-Gro Company announced that they will report Q3, 2025 results at 9:00 AM, Eastern Standard Time on Jul 30, 2025New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Dividend is not well covered by earnings (418% payout ratio). Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results.お知らせ • Jun 05The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Full Fiscal Year 2025The Scotts Miracle-Gro Company reaffirmed earnings guidance for the full fiscal year 2025. For the year, the company expects U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales).Upcoming Dividend • May 16Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 May 2025. Payment date: 06 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.3%. Lower than top quartile of British dividend payers (5.8%). In line with average of industry peers (4.4%).Reported Earnings • May 01Second quarter 2025 earnings released: EPS: US$3.78 (vs US$2.77 in 2Q 2024)Second quarter 2025 results: EPS: US$3.78 (up from US$2.77 in 2Q 2024). Revenue: US$1.42b (down 6.8% from 2Q 2024). Net income: US$217.5m (up 38% from 2Q 2024). Profit margin: 15% (up from 10% in 2Q 2024). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 4.3% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Apr 30Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 34% to US$47.38. The fair value is estimated to be US$62.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.Declared Dividend • Apr 28First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd May 2025 Payment date: 6th June 2025 Dividend yield will be 5.0%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (31% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.お知らせ • Apr 22The Scotts Miracle-Gro Company Declares Quarterly Dividend, Payable on June 6, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on June 6, 2025, to shareholders of record as of May 23, 2025.お知らせ • Apr 17The Scotts Miracle-Gro Company to Report Q2, 2025 Results on Apr 30, 2025The Scotts Miracle-Gro Company announced that they will report Q2, 2025 results Pre-Market on Apr 30, 2025お知らせ • Apr 11An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG).An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025. Under terms of the deal, ScottsMiracle-Gro transferred The Hawthorne Collective to the strategic partner in exchange for an interest-bearing promissory note. The Company retains an option to reacquire The Hawthorne Collective or its assets should cannabis legalization and other measures to positively impact the industry be approved at the federal level. An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025.Buy Or Sell Opportunity • Mar 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to US$56.78. The fair value is estimated to be US$71.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Mar 06the Scotts Miracle-Gro Company Appoints Martha Stewart as Chief Gardening OfficerThe Scotts Miracle-Gro Company announced that lifestyle and gardening expert Martha Stewart has joined Miracle-Gro as Chief Gardening Officer. A self-proclaimed 'Dirt Nerd,' Martha is inherently aligned with the mission of Miracle-Gro to get more Americans outside in their gardens and cultivate creativity with their dirt canvases. Martha Stewart will expand her role as the face of the "Gro Like Martha" campaign by collaborating with Miracle-Gro on exclusive content for Miracle-Gro platforms. This new content series, called "GROwing with Martha Stewart," will feature monthly videos, newsletters, and a downloadable calendar with Martha's product recommendations and gardening insights for all skill levels. Additionally, Martha has a new Gardening Handbook set to release on March 18. As Miracle-Gro's Chief Gardening Officer, Martha will serve as a strategic advisor with an eye toward the future of the brand, providing insights based on her experience and acumen in both business and the garden.お知らせ • Mar 04The Scotts Miracle-Gro Company Appoints Jim Safka as Senior Vice President of EcommerceThe Scotts Miracle-Gro Company announced that Jim Safka has been named senior vice president of ecommerce. Safka is an accomplished executive with extensive and pioneering experience in technology, marketing and management. He previously served as CEO of Match.com, which grew by more than 20% annually under his leadership. He also ran AT&T Wireless’s ecommerce platform, where under his leadership the digital channel generated significant revenue and profitability increases. Previously, he was CEO of Ask.com, ran a venture portfolio and held key product and marketing roles at E-Trade and Intuit. Most recently, Safka was chief marketing officer at CapConnect+, a financial technology company whose digital marketplace simplifies fixed income issuing and investing. Safka holds a bachelor’s degree from the University of Southern California and earned his master’s in management and marketing from the Kellogg School of Management at Northwestern University.Declared Dividend • Feb 03First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 21st February 2025 Payment date: 7th March 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (26% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.お知らせ • Feb 01The Scotts Miracle-Gro Company Appoints Nick Miaritis to Board of DirectorsThe Scotts Miracle-Gro Company announced that Nick Miaritis has been named to its Board of Directors. Miaritis is chief client officer at VaynerMedia, a global creative and media agency, where he leads brand partnerships, accelerates growth opportunities and develops new capabilities. With a passion for crafting culturally relevant content for Fortune 500 brands, he infuses every project with his unique creative vision and strategic edge. Since joining VaynerMedia, he has created leading campaigns, such as Duracell’s “I Buy My Own Batteries” and Planters “Death of Mr. Peanut." Miaritis, a graduate of Georgetown University, is co-founder of the trivia app, FleetWit, and is an advisor to the payments platform Prizeout. He fills the Board seat previously held by Tom Kelly, who retired January 31, 2025, after nearly 20 years as a Board member. Kelly most recently chaired the innovation committee, where he helped guide product strategy and development. The appointment of Miaritis reflects the Board’s focus on adding expanded skills and experiences for fresh perspectives and viewpoints. He is the fifth appointment to the Board since 2022, joining fellow Board members Robert Candelino, Mark Kingdon, Brian Sandoval and Edith Avilés.Reported Earnings • Jan 30First quarter 2025 earnings released: US$1.21 loss per share (vs US$1.42 loss in 1Q 2024)First quarter 2025 results: US$1.21 loss per share (improved from US$1.42 loss in 1Q 2024). Revenue: US$416.8m (up 1.6% from 1Q 2024). Net loss: US$69.5m (loss narrowed 14% from 1Q 2024). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.4% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.お知らせ • Jan 28the Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on March 7, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 7, 2025, to shareholders of record as of February 21, 2025.お知らせ • Jan 15The Scotts Miracle-Gro Company to Report Q1, 2025 Results on Jan 29, 2025The Scotts Miracle-Gro Company announced that they will report Q1, 2025 results Pre-Market on Jan 29, 2025お知らせ • Dec 20The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025.Recent Insider Transactions • Dec 07CEO & Chairman of the Board recently sold US$1.4m worth of stockOn the 4th of December, James Hagedorn sold around 18k shares on-market at roughly US$75.68 per share. This transaction amounted to 20% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.お知らせ • Nov 27+ 1 more updateThe Scotts Miracle-Gro Co. Announces CFO ChangesThe Scotts Miracle-Gro Co. announced expanded responsibilities of Mark Scheiwer, who has served as VP and treasurer since December 2022, becoming interim chief financial officer on January 1, 2025. Matt Garth, who also was chief administrative officer, will depart as CFO on December 31, 2024. He will help facilitate a seamless transition during the time leading up to January 1, 2025. Garth joined Scotts Miracle-Gro as CFO two years ago. The company said Garth's planned departure did not result from any disagreement with the Company or any matter relating to the Company's financial reporting, policies or practices. Scheiwer has more than 13 years of experience in a wide range of finance leadership roles at ScottsMiracle-Gro. The Company will conduct a search for a permanent CFO with the assistance of an executive search firm that is expected to consider internal and external candidates. Scheiwer joined the Company in September 2011 and has held financial roles with increasing responsibility. He previously held a senior audit position with Ernst & Young.Declared Dividend • Nov 11Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd November 2024 Payment date: 6th December 2024 Dividend yield will be 3.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (26% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.Reported Earnings • Nov 07Full year 2024 earnings released: US$0.61 loss per share (vs US$6.79 loss in FY 2023)Full year 2024 results: US$0.61 loss per share (improved from US$6.79 loss in FY 2023). Revenue: US$3.55b (flat on FY 2023). Net loss: US$34.9m (loss narrowed 91% from FY 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 6.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (7.1% average weekly change).お知らせ • Nov 05+ 1 more updateThe Scotts Miracle-Gro Company Appoints Rob Candelino to Board of DirectorsThe Scotts Miracle-Gro Company announced that Rob Candelino has been named to its Board of Directors. Candelino is CEO of PetSafe Brands, the world’s leading pet-technology and services company. He also serves on its Board of Directors. Prior to joining PetSafe, Candelino spent 25 years with Unilever in a variety of roles and with increasing responsibilities, the latest of which was CEO of Unilever Thailand and Regional Head of Inland ASEAN. Candelino has broad and deep global experience in consumer brands, from product development and innovation to marketing, sales and strategy. He has led award-winning initiatives for iconic brands, such as Dove and Dove Men+Care. In 2013, he was inducted into the American Advertising Federation’s Hall of Achievement in recognition of his significant contributions to the advertising and media industry. Candelino is a graduate of The University of Guelph, in Ontario, Canada, where he was recently recognized as a “Notable Alumni” for his accomplishments and philanthropic leadership. He has served on the boards of directors of nonprofit organizations, such as Clean the World Foundation, and the Personal Care Products Council. He fills the Board seat that previously was held by Nancy Mistretta, who retired in January 2024.お知らせ • Oct 23The Scotts Miracle-Gro Company to Report Q4, 2024 Results on Nov 06, 2024The Scotts Miracle-Gro Company announced that they will report Q4, 2024 results Pre-Market on Nov 06, 2024Upcoming Dividend • Aug 19Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 August 2024. Payment date: 06 September 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.7%. Lower than top quartile of British dividend payers (5.5%). Higher than average of industry peers (3.3%).Declared Dividend • Aug 04Third quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd August 2024 Payment date: 6th September 2024 Dividend yield will be 3.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (16% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.New Risk • Aug 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.7% average weekly change).New Risk • Aug 02New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risk Paying a dividend despite being loss-making.Reported Earnings • Aug 01Third quarter 2024 earnings released: EPS: US$2.33 (vs US$0.78 in 3Q 2023)Third quarter 2024 results: EPS: US$2.33 (up from US$0.78 in 3Q 2023). Revenue: US$1.20b (up 7.5% from 3Q 2023). Net income: US$132.1m (up 202% from 3Q 2023). Profit margin: 11% (up from 3.9% in 3Q 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.お知らせ • Jul 31The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment, Payable on September 6, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on September 6, 2024, to shareholders of record as of August 23, 2024.Buy Or Sell Opportunity • Jul 18Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to US$67.32. The fair value is estimated to be US$55.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jun 09Robbins Geller Rudman & Dowd LLP Announces The Scotts Miracle-Gro Company Investors with Substantial Losses Have Opportunity to Lead the Scotts Miracle-Gro Class Action LawsuitRobbins Geller Rudman & Dowd LLP announced that purchasers of The Scotts Miracle-Gro Company common stock between November 3, 2021 and August 1, 2023, inclusive (the “Class Period”), have until August 5, 2024 to seek appointment as lead plaintiff of the Scotts Miracle-Groclass action lawsuit. Captioned City of Hialeah Employees’ Retirement System v. The Scotts Miracle-Gro Company, No. 24-cv-03132 (S.D. Ohio), the Scotts Miracle-Groclass action lawsuit charges Scotts Miracle-Gro and certain of Scotts Miracle-Gro’s top current and former executives with violations of the Securities Exchange Act of 1934. Case Allegations: Scotts Miracle-Gro produces various lawn, garden, and agricultural products for both consumer and professional purposes. The Scotts Miracle-Gro class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Scotts Miracle-Gro had an oversupply of inventory that far exceeded consumer demand; and (ii) Scotts Miracle-Gro executives engaged in a scheme to saturate Scotts Miracle-Gro’s sales channel with more product than those retailers could sell through to end users, a practice that required Scotts Miracle-Gro sales personnel to pressure retailers to purchase more inventory than they wanted or needed. The Scotts Miracle-Gro class action lawsuit further alleges that on June 8, 2022, Scotts Miracle-Gro admitted that replenishment orders from its U.S. retailers were more than $300 million below target in the month of May alone, 2022 full-year earnings would be roughly half of Scotts Miracle-Gro’s prior guidance, and Scotts Miracle-Gro would take on additional debt to cover restructuring charges as it attempted to cut costs. On this news, the price of Scotts Miracle-Gro stock fell nearly 9%, according to the complaint. Then, on August 2, 2023, the Scotts Miracle-Groclass action lawsuit further alleges that Scotts Miracle-Gro disclosed that: (i) it had modified its debt covenants to permit a 7.00 times debt-to-EBITDA ratio, from the original covenant that only permitted a 6.25 times debt-to-EBITDA ratio; (ii) quarterly sales for Scotts Miracle-Gro’s third quarter had declined by 6% and gross margins fell by 420 basis points; and (iii) Scotts Miracle-Gro slashed fiscal year EBITDA guidance by 25% and announced it had to take a $20 million write down for “pandemic driven excess inventories.” On this news, the price of Scotts Miracle-Gro stock fell more than 19%, according to the complaint. The Lead Plaintiff Process: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Scotts Miracle-Gro common stock during the Class Period to seek appointment as lead plaintiff in the Scotts Miracle-Groclass action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Scotts Miracle-Groclass action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Scotts Miracle-Groclass action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Scotts Miracle-Groclass action lawsuit.Upcoming Dividend • May 16Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 May 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (2.8%).Reported Earnings • May 01Second quarter 2024 earnings released: EPS: US$2.77 (vs US$1.95 in 2Q 2023)Second quarter 2024 results: EPS: US$2.77 (up from US$1.95 in 2Q 2023). Revenue: US$1.53b (flat on 2Q 2023). Net income: US$157.5m (up 44% from 2Q 2023). Profit margin: 10% (up from 7.1% in 2Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.Declared Dividend • Apr 29First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd May 2024 Payment date: 7th June 2024 Dividend yield will be 3.9%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (29% cash payout ratio). The dividend has increased by an average of 7.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.お知らせ • Apr 23The Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on June 7, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of quarterly cash dividend of $0.66 per share. The dividend is payable on June 7, 2024, to shareholders of record as of May 24, 2024.お知らせ • Apr 05The Scotts Miracle-Gro Company to Report Q2, 2024 Results on May 01, 2024The Scotts Miracle-Gro Company announced that they will report Q2, 2024 results on May 01, 2024Upcoming Dividend • Feb 15Upcoming dividend of US$0.66 per share at 4.6% yieldEligible shareholders must have bought the stock before 22 February 2024. Payment date: 08 March 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 4.6%. Lower than top quartile of British dividend payers (6.1%). Higher than average of industry peers (3.0%).Reported Earnings • Feb 08First quarter 2024 earnings released: US$1.42 loss per share (vs US$1.17 loss in 1Q 2023)First quarter 2024 results: US$1.42 loss per share (further deteriorated from US$1.17 loss in 1Q 2023). Revenue: US$410.4m (down 22% from 1Q 2023). Net loss: US$80.5m (loss widened 24% from 1Q 2023). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.お知らせ • Jan 31The Scotts Miracle-Gro Company Announces Retirement of Nancy Mistretta from Board of DirectorsThe Scotts Miracle-Gro Company announced that Nancy Mistretta has retired from its Board of Directors. Mistretta has been a director since 2007 and served on various Board committees, most recently as a member of the Audit Committee and the Compensation and Organization Committee.お知らせ • Jan 30The Scotts Miracle-Gro Company to Report Q1, 2024 Results on Feb 07, 2024The Scotts Miracle-Gro Company announced that they will report Q1, 2024 results Pre-Market on Feb 07, 2024Declared Dividend • Jan 29Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd February 2024 Payment date: 8th March 2024 Dividend yield will be 4.5%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (34% cash payout ratio). The dividend has increased by an average of 7.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.お知らせ • Jan 23The Scotts Miracle-Gro Company Approves Quarterly Dividend, Payable on March 8, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 8, 2024, to shareholders of record as of February 23, 2024.Recent Insider Transactions • Dec 17Independent Director recently sold US$278k worth of stockOn the 13th of December, Thomas Kelly sold around 5k shares on-market at roughly US$56.65 per share. This transaction amounted to 48% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$4.3m. Insiders have been net sellers, collectively disposing of US$10.0m more than they bought in the last 12 months.New Risk • Dec 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$4.4m sold).お知らせ • Dec 14The Scotts Miracle-Gro Company, Annual General Meeting, Jan 22, 2024The Scotts Miracle-Gro Company, Annual General Meeting, Jan 22, 2024, at 09:00 US Eastern Standard Time. Agenda: To consider election of four directors, each to serve for a term of three years to expire at the 2027 annual meeting of shareholders; to consider approval on an advisory basis, of the compensation of the company's named executive officers; to consider ratification of selection of Deloitte & Touche LLP as the company's independent registered public for the fiscal year ending September 30, 2024; and to consider other matters.New Risk • Nov 26New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.3% average weekly change). Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Significant insider selling over the past 3 months (US$4.4m sold).お知らせ • Nov 17The Scotts Miracle-Gro Company Announces Executive ChangesOn September 27, 2023, The Scotts Miracle-Gro Company announced that Denise Stump, the Company’s former Executive Vice President, Global Human Resources and Chief Ethics Officer, would be departing the Company on October 1, 2023 (the “Termination Date”). On November 12, 2023, in connection with Ms. Stump’s departure, The Scotts Company LLC, a subsidiary of the Company (“Scotts LLC”), entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Ms. Stump. The Separation Agreement addresses the payments and benefits to which Ms. Stump is entitled in connection with her departure.Upcoming Dividend • Nov 17Upcoming dividend of US$0.66 per share at 4.6% yieldEligible shareholders must have bought the stock before 24 November 2023. Payment date: 08 December 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 4.6%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.1%).Recent Insider Transactions • Nov 07President recently sold US$4.3m worth of stockOn the 3rd of November, James Hagedorn sold around 81k shares on-market at roughly US$53.02 per share. This transaction amounted to 67% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by US$9.1m.Reported Earnings • Nov 01Full year 2023 earnings released: US$6.79 loss per share (vs US$7.88 loss in FY 2022)Full year 2023 results: US$6.79 loss per share (improved from US$7.88 loss in FY 2022). Revenue: US$3.55b (down 9.5% from FY 2022). Net loss: US$380.1m (loss narrowed 13% from FY 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.お知らせ • Nov 01The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on December 8, 2023The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on December 8, 2023, to shareholders of record as of November 27, 2023.お知らせ • Sep 28+ 1 more updateThe Scotts Miracle-Gro Company to Report Fiscal Year 2023 Results on Nov 01, 2023The Scotts Miracle-Gro Company announced that they will report fiscal year 2023 results on Nov 01, 2023お知らせ • Aug 29The Scotts Miracle-Gro Company Announces Executive ChangesThe Scotts Miracle-Gro Company announced that it is executing a succession plan for President and COO Mike Lukemire in preparation for his retirement in fiscal 2024. Under the plan approved by the Board of Directors and agreed upon by Lukemire and Chairman and CEO Jim Hagedorn, Lukemire will step down as COO on September 3, 2023, and retain his position as president until his retirement. In a related move, Nate Baxter, 50, executive vice president of technology &operations, will be promoted to chief operating officer on September 4, 2023, reporting to Lukemire, who will mentor Baxter during a transition period. Lukemire, 65, has been with the Company for almost 28 years, serving as president since February 2016 and COO since January 2015. Baxter joined the Company on April 28, 2023, to oversee research and development, information technology, regulatory, quality and environmental health and safety. In his new role, he additionally will be responsible for supply chain, sales and marketing. He previously was president of TEL U.S., a Tokyo Electron Ltd. subsidiary that manufactures semiconductor and flat panel manufacturing equipment, where he led development, production, sales and marketing. He also worked with Intel Corporation in technology, supply chain, strategy and management. He has undergraduate and advanced degrees from Rollins College and Georgia Institute of Technology, respectively, and is a general partner of the Hagedorn Partnership, L.P.Upcoming Dividend • Aug 17Upcoming dividend of US$0.66 per share at 5.3% yieldEligible shareholders must have bought the stock before 24 August 2023. Payment date: 08 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.3%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (2.8%).Recent Insider Transactions • Aug 08CEO & Chairman of the Board recently sold US$3.1m worth of stockOn the 7th of August, James Hagedorn sold around 55k shares on-market at roughly US$56.32 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by US$4.8m.お知らせ • Aug 03The Scotts Miracle-Gro Company Provides Earnings Guidance for the Full Year 2023The Scotts Miracle-Gro Company provided earnings guidance for the full year 2023. For the period, the company expects total net sales to decline approximately 10% to 11% mainly driven by a net sales decline in the U.S. Consumer segment of 2% to 4% and a net sales decline of 30% to 35% in the Hawthorne segment. Additionally, operating income is expected to range from 7% to 7.5% of sales for the year.Reported Earnings • Aug 03Third quarter 2023 earnings released: EPS: US$0.78 (vs US$8.01 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.78 (up from US$8.01 loss in 3Q 2022). Revenue: US$1.12b (down 5.7% from 3Q 2022). Net income: US$43.7m (up US$487.6m from 3Q 2022). Profit margin: 3.9% (up from net loss in 3Q 2022). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 02The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on September 8, 2023The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on September 8, 2023, to shareholders of record as of August 25, 2023.Buying Opportunity • Jul 29Now 20% undervaluedOver the last 90 days, the stock is up 5.8%. The fair value is estimated to be US$88.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.お知らせ • Jul 23The Scotts Miracle-Gro Company to Report Q3, 2023 Results on Aug 02, 2023The Scotts Miracle-Gro Company announced that they will report Q3, 2023 results Pre-Market on Aug 02, 2023お知らせ • Jul 15The Scotts Miracle-Gro Company Announces Board ChangesThe Scotts Miracle-Gro Company announced that Mark D. Kingdon has been named to its Board of Directors. Kingdon has held senior executive positions ranging from president and CEO to founder of companies in the consumer, technology and digital spaces, among others. He has experience in finance, marketing, branding, innovation, business transformation and emerging technologies with a track record of achieving groundbreaking results. Kingdon is founder of Quixotic Ventures, which invests in early stage consumer internet companies, and held board seats with TheRealReal.com, SAY Media Inc., Linden Lab and Organic Inc. as well as several nonprofits, such as Miami’s New World Symphony. He previously was CEO of Linden Lab (developer of Second Life - the early metaverse) and Organic Inc. He also was a managing partner at PwC, where he ran the retail and distribution industries consulting practice for the Americas. He holds an MBA from the Wharton School of Business, University of Pennsylvania, and a Bachelor of Arts in Economics from the University of California, Los Angeles. Kingdon succeeds Gerald Volas, who resigned from the Board.Buying Opportunity • Jul 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 6.4%. The fair value is estimated to be US$88.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.株主還元0L45GB ChemicalsGB 市場7D11.1%3.3%1.0%1Y3.0%5.4%17.6%株主還元を見る業界別リターン: 0L45過去 1 年間で5.4 % の収益を上げたUK Chemicals業界を下回りました。リターン対市場: 0L45は、過去 1 年間で17.6 % のリターンを上げたUK市場を下回りました。価格変動Is 0L45's price volatile compared to industry and market?0L45 volatility0L45 Average Weekly Movement6.6%Chemicals Industry Average Movement7.1%Market Average Movement5.6%10% most volatile stocks in GB Market11.8%10% least volatile stocks in GB Market3.1%安定した株価: 0L45 、 UK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 0L45の 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト18685,200Jim Hagedornscottsmiraclegro.comスコッツ・ミラクル・グロー・カンパニーは、その子会社とともに、米国内外で芝生、ガーデンケア、屋内および水耕栽培用の製品の製造、マーケティング、販売に従事している。同社は、芝生用肥料、クローバーや芝の種子製品、散布機、その他の耐久製品、芝生に関連する雑草、害虫、病害の防除製品からなる芝生ケア製品、および水溶性・徐放性植物食品、鉢植え用ミックス、庭用土、マルチング材、グランドカバー製品、植物に関連する害虫・病害の防除製品、オーガニックガーデン製品、ライブグッズ、シードソリューションを含むガーデニング・造園製品を提供している。また、土をほとんど使わず植物、花、野菜を栽培できる水耕栽培製品、照明システムおよび部品、家庭用の昆虫、げっ歯類、雑草駆除製品、非選択性除草剤も提供している。同社はScotts、Turf Builder、Grower's Edge、EZ Seed、PatchMaster、Thick'R Lawn、GrubEx、EdgeGuard、Whirl、Wizz、Miracle-Gro、LiquaFeed、Shake 'N Feed、Hyponex、Earthgro、Miracle-Gro Organic、CAN-FAN、CAN-FILTERS、EcoPlus、Bug B Gon、Nature Scapes、Ortho、Miracle-Gro Performance Organics、Miracle-Gro Organic Choice、Whitney Farms、Ortho Max、Home Defense、Mother Earth、Botanicare、General Hydroponics、CYCO、Gavita、Agrolux、HydroLogic Purification System、Gro Pro、AeroGarden、Titan、Tomcat、Ortho Weed B Gon、Roundup、Groundclear、Alchemistブランド。ホームセンター、量販店、倉庫クラブ、大手金物チェーン、独立系金物店、ナーセリー、ガーデンセンター、eコマースプラットフォーム、食品・ドラッグストア、屋内園芸・水耕栽培の販売業者、小売業者、栽培業者にサービスを提供している。以前はザ・スコッツ・カンパニーとして知られていた。スコッツ・ミラクル・グロ社は1868年に設立され、オハイオ州メアリスビルに本社を置いている。もっと見るThe Scotts Miracle-Gro Company 基礎のまとめScotts Miracle-Gro の収益と売上を時価総額と比較するとどうか。0L45 基礎統計学時価総額US$3.59b収益（TTM）US$206.10m売上高(TTM)US$3.47b17.8xPER（株価収益率1.1xP/Sレシオ0L45 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0L45 損益計算書（TTM）収益US$3.47b売上原価US$2.34b売上総利益US$1.13bその他の費用US$921.60m収益US$206.10m直近の収益報告Mar 28, 2026次回決算日Jul 29, 2026一株当たり利益（EPS）3.54グロス・マージン32.49%純利益率5.94%有利子負債／自己資本比率-814.8%0L45 の長期的なパフォーマンスは？過去の実績と比較を見る配当金4.2%現在の配当利回り74%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/15 01:04終値2026/06/15 00:00収益2026/03/28年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The Scotts Miracle-Gro Company 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。17 アナリスト機関Alexander MarocciaBerenbergConstance ManeatyBMO Capital Markets Equity ResearchChristopher CareyBofA Global Research14 その他のアナリストを表示
Buy Or Sell Opportunity • May 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to US$58.93. The fair value is estimated to be US$74.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Upcoming Dividend • May 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 May 2026. Payment date: 05 June 2026. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (3.9%).
Buy Or Sell Opportunity • May 10Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to US$61.67. The fair value is estimated to be US$77.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
お知らせ • May 01the Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal 2026. For the period, the company re-affirmed U.S. Consumer net sales low single-digit growth.
Reported Earnings • Apr 30Second quarter 2026 earnings released: EPS: US$4.53 (vs US$3.78 in 2Q 2025)Second quarter 2026 results: EPS: US$4.53 (up from US$3.78 in 2Q 2025). Revenue: US$1.46b (up 2.7% from 2Q 2025). Net income: US$263.3m (up 21% from 2Q 2025). Profit margin: 18% (up from 15% in 2Q 2025). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 7.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
New Risk • Apr 30New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Earnings have declined by 26% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (93% payout ratio). Large one-off items impacting financial results.
Buy Or Sell Opportunity • May 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to US$58.93. The fair value is estimated to be US$74.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Upcoming Dividend • May 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 May 2026. Payment date: 05 June 2026. Payout ratio is a comfortable 74% and this is well supported by cash flows. Trailing yield: 4.5%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (3.9%).
Buy Or Sell Opportunity • May 10Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to US$61.67. The fair value is estimated to be US$77.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 1.2% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
お知らせ • May 01the Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal 2026. For the period, the company re-affirmed U.S. Consumer net sales low single-digit growth.
Reported Earnings • Apr 30Second quarter 2026 earnings released: EPS: US$4.53 (vs US$3.78 in 2Q 2025)Second quarter 2026 results: EPS: US$4.53 (up from US$3.78 in 2Q 2025). Revenue: US$1.46b (up 2.7% from 2Q 2025). Net income: US$263.3m (up 21% from 2Q 2025). Profit margin: 18% (up from 15% in 2Q 2025). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 7.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
New Risk • Apr 30New major risk - Revenue and earnings growthEarnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Earnings have declined by 26% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (93% payout ratio). Large one-off items impacting financial results.
Declared Dividend • Apr 26First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd May 2026 Payment date: 5th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is well covered by cash flows (43% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 81% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Apr 23The Scotts Miracle-Gro Company to Report Q2, 2026 Results on Apr 29, 2026The Scotts Miracle-Gro Company announced that they will report Q2, 2026 results Pre-Market on Apr 29, 2026
お知らせ • Apr 21The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on June 5, 2026The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a quarterly cash dividend of $0.66 per share. The dividend is payable on June 5, 2026, to shareholders of record as of May 22, 2026.
Buy Or Sell Opportunity • Mar 27Now 25% undervaluedOver the last 90 days, the stock has risen 4.5% to US$61.69. The fair value is estimated to be US$81.85, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.6% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 0.6% in 2 years. Earnings are forecast to grow by 74% in the next 2 years.
お知らせ • Mar 18ScottsMiracle-Gro, Bonnie Plants And Gardenuity Launches Inspired To Gro Patio Garden CollectionScottsMiracle-Gro, Bonnie Plants and Gardenuity announced the launch of the Inspired to Gro Patio Garden Collection, a fully integrated gardening experience designed to help new and emerging gardeners grow successfully from day one. Inspired to Gro combines ScottsMiracle-Gro’s plant nutrients, Bonnie Plants’ fully rooted starter plants and Gardenuity’s guided gardening platform – including its curated container garden design, integrated growing components and personalized guidance platform – into a single product offering. This strategic collaboration between three leaders in the lawn and garden industry aims to remove the barriers that have historically prevented millions of interested consumers from starting and sustaining a garden. Inspired to Gro delivers everything needed to plant, grow and thrive in one seamless experience. While millions of Americans express interest in gardening, many struggle with where to begin or how to maintain success over time. Inspired to Gro addresses the barriers. Gardenuity was founded on the belief that gardening should be accessible to everyone, regardless of experience or space. Inspired to Gro removes the uncertainty that keeps so many people from starting by giving them the tools, plants and guided support they need to grow successfully from day one. The launch comes as consumers increasingly prioritize wellness, sustainability and fresh food access, fueling renewed interest in home gardening. Bonnie Plants, which has supplied vegetable and herb plants to American gardeners for more than a century, sees the collaboration as an important step in expanding access to gardening. For more than 100 years, Bonnie Plants has helped people grow their own food at home. Inspired to Gro builds on that legacy by making gardening more approachable and successful for more people. The collection features thoughtfully curated plant selections to support wellness, nourishment and enjoyment. The Inspired to Gro Patio Garden Collection includes three distinct offerings — Everyday Good Seasonal Herb Garden, Well Bloomed Limited Edition Edible Flower and Seasonal Herb Garden and Simply Rooted Seasonal Vegetable and Herb Garden. Inspired to Gro is now available on Amazon, Bonnieplants.com and Gardenuity.com with plans to expand to other ecommerce sites. Each Inspired to Gro garden includes: Gardenuity’s signature 5-gallon, double-stitched grow bag with reinforced handles for optimal root health and durability. Custom-blended soil, formulated specifically for container growing success. Four fully rooted Bonnie Plants selected and aligned to the consumer’s location and seasonal growing conditions. Miracle-Gro Pour & Feed Plant Food to provide essential nutrients to support plant growth and vitality. Grow Pro support from Gardenuity, including personalized guidance and weather-based garden notifications to help ensure ongoing success.
Upcoming Dividend • Feb 15Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 20 February 2026. Payment date: 06 March 2026. Payout ratio is on the higher end at 93%, however this is supported by cash flows. Trailing yield: 3.9%. Lower than top quartile of British dividend payers (5.3%). Higher than average of industry peers (3.5%).
お知らせ • Feb 04Miracle-Gro Introduces Refreshed Lineup of Their Indoor Soils and Plant FoodsMiracle-Gro introduced a refreshed lineup of their indoor soils and plant foods. In addition, they are launching new plant care solutions, plus a brand new organic plant food item designed to make indoor gardening an approachable form of self-care, helping people nurture their homes while supporting their well-being. Research shows Americans are nearly twice as likely to report a decline in mood during the winter months (41%) than an improvement (22%). Indoor gardening offers a calming, screen-free way to restore routine, confidence and a sense of progress rooted in care and growth. With simple, intuitive solutions, Miracle-Gro's refreshed indoor assortment removes the guesswork from plant care, making it easy for anyone - from first-time plant parents to seasoned growers - to build a wellness habit that fits seamlessly into everyday life. The updated lineup features over 10 best-selling Miracle-Gro indoor products with clearer, easier-to-shop packaging, designed to reduce decision fatigue and help shoppers quickly find the right solution for their plants. In addition, two new plant care solutions designed to combat pesky insects while beautifying plants, and one new easy-to-use organic plant food solution. Highlights from the refreshed indoor portfolio & new items include: Miracle-Gro Indoor Potting Mixes: Tailored mixes for All Plants, Cactus & Succulent, Tropicals, Orchids and Seed Starting support healthier growth with less guesswork. Miracle-Gro Indoor Plant Foods: Easy-to-use liquid plant foods deliver essential nutrients for stronger, healthier indoor plants. The variety includes All Plants, Cactus &Succulent, Tropicals,Orchids and Plant Food Spikes for All Plants. Miracle-Gro Organic Indoor Plant Food: Made from 94% plant based fertilizer ingredients, this new organic plant food provides instant nourishment for healthier, more resilient plants (vs unfed plants when used as directed). Miracle-Gro Plant Care Flying insect Traps: A sleek, double-sided leaf shaped design that blends seamlessly into plants while quietly capturing flying insects before they can damage roots - protecting both plants and peace of mind. Miracle-Gro Plant Care Leaf Protect & Shine: Gentle on plants and tough on pests, this solution helps protect against common houseplant issues, while beautifying natural leaf shine. Products range from $4.97 - $17.99 and are available at scottsmiraclegro.com and select national retailers, including Amazon, Home Depot, Target and Walmart. Availability may vary by product and retailer. For specific tips and tricks on indoor gardening, you can visit the Miracle-Gro website for helpful blog posts.
Declared Dividend • Feb 01First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 20th February 2026 Payment date: 6th March 2026 Dividend yield will be 4.1%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not adequately covered by earnings (93% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 3.6% to bring the payout ratio under control. EPS is expected to grow by 67% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Jan 29The Scotts Miracle-Gro Company (NYSE:SMG) announces an Equity Buyback for $500 million worth of its shares.The Scotts Miracle-Gro Company (NYSE:SMG) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its shares. The repurchase program has no time limit.
Reported Earnings • Jan 29First quarter 2026 earnings released: US$0.83 loss per share (vs US$1.21 loss in 1Q 2025)First quarter 2026 results: US$0.83 loss per share (improved from US$1.21 loss in 1Q 2025). Revenue: US$354.4m (down 15% from 1Q 2025). Net loss: US$47.8m (loss narrowed 31% from 1Q 2025). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Jan 28The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Fiscal Year 2026The Scotts Miracle-Gro Company reaffirmed earnings guidance for the fiscal year 2026. For the year, the company expects U.S. Consumer net sales low single-digit growth.
お知らせ • Jan 27The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on March 6, 2026The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 6, 2026, to shareholders of record as of February 20, 2026.
お知らせ • Jan 20The Scotts Miracle-Gro Company to Report Q1, 2026 Results on Jan 28, 2026The Scotts Miracle-Gro Company announced that they will report Q1, 2026 results at 9:00 AM, Eastern Standard Time on Jan 28, 2026
お知らせ • Dec 18The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026The Scotts Miracle-Gro Company, Annual General Meeting, Jan 26, 2026.
Declared Dividend • Nov 09Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 21st November 2025 Payment date: 5th December 2025 Dividend yield will be 4.7%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (105% earnings payout ratio). However, it is covered by cash flows (56% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 16% to bring the payout ratio under control. EPS is expected to grow by 62% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • Nov 06Full year 2025 earnings released: EPS: US$2.52 (vs US$0.61 loss in FY 2024)Full year 2025 results: EPS: US$2.52 (up from US$0.61 loss in FY 2024). Revenue: US$3.41b (down 3.9% from FY 2024). Net income: US$145.2m (up US$180.1m from FY 2024). Profit margin: 4.3% (up from net loss in FY 2024). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Nov 06+ 1 more updateThe Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on December 5, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on December 5, 2025, to shareholders of record as of November 21, 2025.
お知らせ • Oct 23The Scotts Miracle-Gro Company to Report Q4, 2025 Results on Nov 05, 2025The Scotts Miracle-Gro Company announced that they will report Q4, 2025 results Pre-Market on Nov 05, 2025
Board Change • Sep 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Austin Miller was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Aug 18Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 22 August 2025. Payment date: 05 September 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.2%. Lower than top quartile of British dividend payers (5.5%). In line with average of industry peers (4.3%).
お知らせ • Aug 06The Scotts Miracle-Gro Company Announces Changes to Board of DirectorsThe Scotts Miracle-Gro Company announced changes to its Board of Directors. Former U.S. Army Lt. General John R. Vines announced his retirement after more than 12 years on the Board, most recently as a member of the Nominating & Governance and Innovation & Technology committees. His term was set to expire at the 2027 annual meeting of shareholders. Although he no longer is a member of the Board, he will maintain an advisory role as Board member emeritus. Vines served 35 years in the military, commanding the U.S. Army’s XVII Airborne Corps and 27-nation Multi-National Corps in Iraq and the Combined Joint Task Force and 82nd Airborne Division in Afghanistan. Replacing Vines is retired U.S. Army General Scott Miller, who commanded at all grades, most notably as commanding general of the U.S. Army Maneuver Center at Fort Benning and as commander of the Joint Special Operations Command, where he directed U.S. operations in complex geopolitical regions including the Indo-Pacific, Africa, Middle East and South Asia. He also commanded assault forces in Mogadishu, Somalia, during “Blackhawk Down.” His numerous decorations and honors include two awards of the coveted Combat Infantryman Badge, two Purple Hearts, the Silver Star and an unprecedented 20 Overseas Service Bars denoting more than 10 full years in combat zones. In 2023, he was selected as a distinguished graduate of the United States Military Academy and the recipient of the Richard M. Helms Award presented by the CIA Memorial Foundation. In retirement, Miller has pursued an understanding of business serving in both leadership roles and board positions. Through the Miller Advisory Group he consults overseas, speaks on world topics and hosts leadership retreats. He is a senior fellow for the Combating Terrorism Center at the U.S. Military Academy, where he mentors future leaders, and is an ambassador for the nonprofit Shields and Stripes, which is focused on veterans and first responders.
Declared Dividend • Aug 04Third quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd August 2025 Payment date: 5th September 2025 Dividend yield will be 4.3%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is not covered by earnings (285% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 3.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 217% to bring the payout ratio under control. EPS is expected to grow by 116% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
Reported Earnings • Aug 01Third quarter 2025 earnings released: EPS: US$2.58 (vs US$2.33 in 3Q 2024)Third quarter 2025 results: EPS: US$2.58 (up from US$2.33 in 3Q 2024). Revenue: US$1.19b (down 1.2% from 3Q 2024). Net income: US$149.1m (up 13% from 3Q 2024). Profit margin: 13% (up from 11% in 3Q 2024). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
お知らせ • Jul 30+ 1 more updateThe Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Full Year Fiscal 2025The Scotts Miracle-Gro Company reaffirmed earnings guidance for the full year fiscal 2025. U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales).
お知らせ • Jul 17The Scotts Miracle-Gro Company to Report Q3, 2025 Results on Jul 30, 2025The Scotts Miracle-Gro Company announced that they will report Q3, 2025 results at 9:00 AM, Eastern Standard Time on Jul 30, 2025
New Risk • Jun 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Dividend is not well covered by earnings (418% payout ratio). Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results.
お知らせ • Jun 05The Scotts Miracle-Gro Company Reaffirms Earnings Guidance for the Full Fiscal Year 2025The Scotts Miracle-Gro Company reaffirmed earnings guidance for the full fiscal year 2025. For the year, the company expects U.S. Consumer net sales low single-digit growth (excluding non-repeat sales for AeroGarden and bulk raw material sales).
Upcoming Dividend • May 16Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 May 2025. Payment date: 06 June 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.3%. Lower than top quartile of British dividend payers (5.8%). In line with average of industry peers (4.4%).
Reported Earnings • May 01Second quarter 2025 earnings released: EPS: US$3.78 (vs US$2.77 in 2Q 2024)Second quarter 2025 results: EPS: US$3.78 (up from US$2.77 in 2Q 2024). Revenue: US$1.42b (down 6.8% from 2Q 2024). Net income: US$217.5m (up 38% from 2Q 2024). Profit margin: 15% (up from 10% in 2Q 2024). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 4.3% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Apr 30Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 34% to US$47.38. The fair value is estimated to be US$62.49, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.
Declared Dividend • Apr 28First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd May 2025 Payment date: 6th June 2025 Dividend yield will be 5.0%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (31% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
お知らせ • Apr 22The Scotts Miracle-Gro Company Declares Quarterly Dividend, Payable on June 6, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on June 6, 2025, to shareholders of record as of May 23, 2025.
お知らせ • Apr 17The Scotts Miracle-Gro Company to Report Q2, 2025 Results on Apr 30, 2025The Scotts Miracle-Gro Company announced that they will report Q2, 2025 results Pre-Market on Apr 30, 2025
お知らせ • Apr 11An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG).An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025. Under terms of the deal, ScottsMiracle-Gro transferred The Hawthorne Collective to the strategic partner in exchange for an interest-bearing promissory note. The Company retains an option to reacquire The Hawthorne Collective or its assets should cannabis legalization and other measures to positively impact the industry be approved at the federal level. An undisclosed buyer acquired The Hawthorne Collective, Inc. from The Scotts Miracle-Gro Company (NYSE:SMG) on April 10, 2025.
Buy Or Sell Opportunity • Mar 25Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to US$56.78. The fair value is estimated to be US$71.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Mar 06the Scotts Miracle-Gro Company Appoints Martha Stewart as Chief Gardening OfficerThe Scotts Miracle-Gro Company announced that lifestyle and gardening expert Martha Stewart has joined Miracle-Gro as Chief Gardening Officer. A self-proclaimed 'Dirt Nerd,' Martha is inherently aligned with the mission of Miracle-Gro to get more Americans outside in their gardens and cultivate creativity with their dirt canvases. Martha Stewart will expand her role as the face of the "Gro Like Martha" campaign by collaborating with Miracle-Gro on exclusive content for Miracle-Gro platforms. This new content series, called "GROwing with Martha Stewart," will feature monthly videos, newsletters, and a downloadable calendar with Martha's product recommendations and gardening insights for all skill levels. Additionally, Martha has a new Gardening Handbook set to release on March 18. As Miracle-Gro's Chief Gardening Officer, Martha will serve as a strategic advisor with an eye toward the future of the brand, providing insights based on her experience and acumen in both business and the garden.
お知らせ • Mar 04The Scotts Miracle-Gro Company Appoints Jim Safka as Senior Vice President of EcommerceThe Scotts Miracle-Gro Company announced that Jim Safka has been named senior vice president of ecommerce. Safka is an accomplished executive with extensive and pioneering experience in technology, marketing and management. He previously served as CEO of Match.com, which grew by more than 20% annually under his leadership. He also ran AT&T Wireless’s ecommerce platform, where under his leadership the digital channel generated significant revenue and profitability increases. Previously, he was CEO of Ask.com, ran a venture portfolio and held key product and marketing roles at E-Trade and Intuit. Most recently, Safka was chief marketing officer at CapConnect+, a financial technology company whose digital marketplace simplifies fixed income issuing and investing. Safka holds a bachelor’s degree from the University of Southern California and earned his master’s in management and marketing from the Kellogg School of Management at Northwestern University.
Declared Dividend • Feb 03First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 21st February 2025 Payment date: 7th March 2025 Dividend yield will be 3.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (26% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
お知らせ • Feb 01The Scotts Miracle-Gro Company Appoints Nick Miaritis to Board of DirectorsThe Scotts Miracle-Gro Company announced that Nick Miaritis has been named to its Board of Directors. Miaritis is chief client officer at VaynerMedia, a global creative and media agency, where he leads brand partnerships, accelerates growth opportunities and develops new capabilities. With a passion for crafting culturally relevant content for Fortune 500 brands, he infuses every project with his unique creative vision and strategic edge. Since joining VaynerMedia, he has created leading campaigns, such as Duracell’s “I Buy My Own Batteries” and Planters “Death of Mr. Peanut." Miaritis, a graduate of Georgetown University, is co-founder of the trivia app, FleetWit, and is an advisor to the payments platform Prizeout. He fills the Board seat previously held by Tom Kelly, who retired January 31, 2025, after nearly 20 years as a Board member. Kelly most recently chaired the innovation committee, where he helped guide product strategy and development. The appointment of Miaritis reflects the Board’s focus on adding expanded skills and experiences for fresh perspectives and viewpoints. He is the fifth appointment to the Board since 2022, joining fellow Board members Robert Candelino, Mark Kingdon, Brian Sandoval and Edith Avilés.
Reported Earnings • Jan 30First quarter 2025 earnings released: US$1.21 loss per share (vs US$1.42 loss in 1Q 2024)First quarter 2025 results: US$1.21 loss per share (improved from US$1.42 loss in 1Q 2024). Revenue: US$416.8m (up 1.6% from 1Q 2024). Net loss: US$69.5m (loss narrowed 14% from 1Q 2024). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.4% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 28the Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on March 7, 2025The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 7, 2025, to shareholders of record as of February 21, 2025.
お知らせ • Jan 15The Scotts Miracle-Gro Company to Report Q1, 2025 Results on Jan 29, 2025The Scotts Miracle-Gro Company announced that they will report Q1, 2025 results Pre-Market on Jan 29, 2025
お知らせ • Dec 20The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025The Scotts Miracle-Gro Company, Annual General Meeting, Jan 27, 2025.
Recent Insider Transactions • Dec 07CEO & Chairman of the Board recently sold US$1.4m worth of stockOn the 4th of December, James Hagedorn sold around 18k shares on-market at roughly US$75.68 per share. This transaction amounted to 20% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was James' only on-market trade for the last 12 months.
お知らせ • Nov 27+ 1 more updateThe Scotts Miracle-Gro Co. Announces CFO ChangesThe Scotts Miracle-Gro Co. announced expanded responsibilities of Mark Scheiwer, who has served as VP and treasurer since December 2022, becoming interim chief financial officer on January 1, 2025. Matt Garth, who also was chief administrative officer, will depart as CFO on December 31, 2024. He will help facilitate a seamless transition during the time leading up to January 1, 2025. Garth joined Scotts Miracle-Gro as CFO two years ago. The company said Garth's planned departure did not result from any disagreement with the Company or any matter relating to the Company's financial reporting, policies or practices. Scheiwer has more than 13 years of experience in a wide range of finance leadership roles at ScottsMiracle-Gro. The Company will conduct a search for a permanent CFO with the assistance of an executive search firm that is expected to consider internal and external candidates. Scheiwer joined the Company in September 2011 and has held financial roles with increasing responsibility. He previously held a senior audit position with Ernst & Young.
Declared Dividend • Nov 11Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd November 2024 Payment date: 6th December 2024 Dividend yield will be 3.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (26% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
Reported Earnings • Nov 07Full year 2024 earnings released: US$0.61 loss per share (vs US$6.79 loss in FY 2023)Full year 2024 results: US$0.61 loss per share (improved from US$6.79 loss in FY 2023). Revenue: US$3.55b (flat on FY 2023). Net loss: US$34.9m (loss narrowed 91% from FY 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 6.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 25% per year, which means it has not declined as severely as earnings.
New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (7.1% average weekly change).
お知らせ • Nov 05+ 1 more updateThe Scotts Miracle-Gro Company Appoints Rob Candelino to Board of DirectorsThe Scotts Miracle-Gro Company announced that Rob Candelino has been named to its Board of Directors. Candelino is CEO of PetSafe Brands, the world’s leading pet-technology and services company. He also serves on its Board of Directors. Prior to joining PetSafe, Candelino spent 25 years with Unilever in a variety of roles and with increasing responsibilities, the latest of which was CEO of Unilever Thailand and Regional Head of Inland ASEAN. Candelino has broad and deep global experience in consumer brands, from product development and innovation to marketing, sales and strategy. He has led award-winning initiatives for iconic brands, such as Dove and Dove Men+Care. In 2013, he was inducted into the American Advertising Federation’s Hall of Achievement in recognition of his significant contributions to the advertising and media industry. Candelino is a graduate of The University of Guelph, in Ontario, Canada, where he was recently recognized as a “Notable Alumni” for his accomplishments and philanthropic leadership. He has served on the boards of directors of nonprofit organizations, such as Clean the World Foundation, and the Personal Care Products Council. He fills the Board seat that previously was held by Nancy Mistretta, who retired in January 2024.
お知らせ • Oct 23The Scotts Miracle-Gro Company to Report Q4, 2024 Results on Nov 06, 2024The Scotts Miracle-Gro Company announced that they will report Q4, 2024 results Pre-Market on Nov 06, 2024
Upcoming Dividend • Aug 19Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 August 2024. Payment date: 06 September 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.7%. Lower than top quartile of British dividend payers (5.5%). Higher than average of industry peers (3.3%).
Declared Dividend • Aug 04Third quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd August 2024 Payment date: 6th September 2024 Dividend yield will be 3.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (16% cash payout ratio). The dividend has increased by an average of 4.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
New Risk • Aug 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (6.7% average weekly change).
New Risk • Aug 02New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risk Paying a dividend despite being loss-making.
Reported Earnings • Aug 01Third quarter 2024 earnings released: EPS: US$2.33 (vs US$0.78 in 3Q 2023)Third quarter 2024 results: EPS: US$2.33 (up from US$0.78 in 3Q 2023). Revenue: US$1.20b (up 7.5% from 3Q 2023). Net income: US$132.1m (up 202% from 3Q 2023). Profit margin: 11% (up from 3.9% in 3Q 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance.
お知らせ • Jul 31The Scotts Miracle-Gro Company Announces Quarterly Dividend Payment, Payable on September 6, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on September 6, 2024, to shareholders of record as of August 23, 2024.
Buy Or Sell Opportunity • Jul 18Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to US$67.32. The fair value is estimated to be US$55.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 15% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jun 09Robbins Geller Rudman & Dowd LLP Announces The Scotts Miracle-Gro Company Investors with Substantial Losses Have Opportunity to Lead the Scotts Miracle-Gro Class Action LawsuitRobbins Geller Rudman & Dowd LLP announced that purchasers of The Scotts Miracle-Gro Company common stock between November 3, 2021 and August 1, 2023, inclusive (the “Class Period”), have until August 5, 2024 to seek appointment as lead plaintiff of the Scotts Miracle-Groclass action lawsuit. Captioned City of Hialeah Employees’ Retirement System v. The Scotts Miracle-Gro Company, No. 24-cv-03132 (S.D. Ohio), the Scotts Miracle-Groclass action lawsuit charges Scotts Miracle-Gro and certain of Scotts Miracle-Gro’s top current and former executives with violations of the Securities Exchange Act of 1934. Case Allegations: Scotts Miracle-Gro produces various lawn, garden, and agricultural products for both consumer and professional purposes. The Scotts Miracle-Gro class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Scotts Miracle-Gro had an oversupply of inventory that far exceeded consumer demand; and (ii) Scotts Miracle-Gro executives engaged in a scheme to saturate Scotts Miracle-Gro’s sales channel with more product than those retailers could sell through to end users, a practice that required Scotts Miracle-Gro sales personnel to pressure retailers to purchase more inventory than they wanted or needed. The Scotts Miracle-Gro class action lawsuit further alleges that on June 8, 2022, Scotts Miracle-Gro admitted that replenishment orders from its U.S. retailers were more than $300 million below target in the month of May alone, 2022 full-year earnings would be roughly half of Scotts Miracle-Gro’s prior guidance, and Scotts Miracle-Gro would take on additional debt to cover restructuring charges as it attempted to cut costs. On this news, the price of Scotts Miracle-Gro stock fell nearly 9%, according to the complaint. Then, on August 2, 2023, the Scotts Miracle-Groclass action lawsuit further alleges that Scotts Miracle-Gro disclosed that: (i) it had modified its debt covenants to permit a 7.00 times debt-to-EBITDA ratio, from the original covenant that only permitted a 6.25 times debt-to-EBITDA ratio; (ii) quarterly sales for Scotts Miracle-Gro’s third quarter had declined by 6% and gross margins fell by 420 basis points; and (iii) Scotts Miracle-Gro slashed fiscal year EBITDA guidance by 25% and announced it had to take a $20 million write down for “pandemic driven excess inventories.” On this news, the price of Scotts Miracle-Gro stock fell more than 19%, according to the complaint. The Lead Plaintiff Process: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Scotts Miracle-Gro common stock during the Class Period to seek appointment as lead plaintiff in the Scotts Miracle-Groclass action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Scotts Miracle-Groclass action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Scotts Miracle-Groclass action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Scotts Miracle-Groclass action lawsuit.
Upcoming Dividend • May 16Upcoming dividend of US$0.66 per shareEligible shareholders must have bought the stock before 23 May 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.8%. Lower than top quartile of British dividend payers (5.7%). Higher than average of industry peers (2.8%).
Reported Earnings • May 01Second quarter 2024 earnings released: EPS: US$2.77 (vs US$1.95 in 2Q 2023)Second quarter 2024 results: EPS: US$2.77 (up from US$1.95 in 2Q 2023). Revenue: US$1.53b (flat on 2Q 2023). Net income: US$157.5m (up 44% from 2Q 2023). Profit margin: 10% (up from 7.1% in 2Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
Declared Dividend • Apr 29First quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 23rd May 2024 Payment date: 7th June 2024 Dividend yield will be 3.9%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (29% cash payout ratio). The dividend has increased by an average of 7.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
お知らせ • Apr 23The Scotts Miracle-Gro Company Announces Quarterly Dividend, Payable on June 7, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of quarterly cash dividend of $0.66 per share. The dividend is payable on June 7, 2024, to shareholders of record as of May 24, 2024.
お知らせ • Apr 05The Scotts Miracle-Gro Company to Report Q2, 2024 Results on May 01, 2024The Scotts Miracle-Gro Company announced that they will report Q2, 2024 results on May 01, 2024
Upcoming Dividend • Feb 15Upcoming dividend of US$0.66 per share at 4.6% yieldEligible shareholders must have bought the stock before 22 February 2024. Payment date: 08 March 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 4.6%. Lower than top quartile of British dividend payers (6.1%). Higher than average of industry peers (3.0%).
Reported Earnings • Feb 08First quarter 2024 earnings released: US$1.42 loss per share (vs US$1.17 loss in 1Q 2023)First quarter 2024 results: US$1.42 loss per share (further deteriorated from US$1.17 loss in 1Q 2023). Revenue: US$410.4m (down 22% from 1Q 2023). Net loss: US$80.5m (loss widened 24% from 1Q 2023). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
お知らせ • Jan 31The Scotts Miracle-Gro Company Announces Retirement of Nancy Mistretta from Board of DirectorsThe Scotts Miracle-Gro Company announced that Nancy Mistretta has retired from its Board of Directors. Mistretta has been a director since 2007 and served on various Board committees, most recently as a member of the Audit Committee and the Compensation and Organization Committee.
お知らせ • Jan 30The Scotts Miracle-Gro Company to Report Q1, 2024 Results on Feb 07, 2024The Scotts Miracle-Gro Company announced that they will report Q1, 2024 results Pre-Market on Feb 07, 2024
Declared Dividend • Jan 29Fourth quarter dividend of US$0.66 announcedDividend of US$0.66 is the same as last year. Ex-date: 22nd February 2024 Payment date: 8th March 2024 Dividend yield will be 4.5%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (34% cash payout ratio). The dividend has increased by an average of 7.3% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
お知らせ • Jan 23The Scotts Miracle-Gro Company Approves Quarterly Dividend, Payable on March 8, 2024The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on March 8, 2024, to shareholders of record as of February 23, 2024.
Recent Insider Transactions • Dec 17Independent Director recently sold US$278k worth of stockOn the 13th of December, Thomas Kelly sold around 5k shares on-market at roughly US$56.65 per share. This transaction amounted to 48% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$4.3m. Insiders have been net sellers, collectively disposing of US$10.0m more than they bought in the last 12 months.
New Risk • Dec 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Significant insider selling over the past 3 months (US$4.4m sold).
お知らせ • Dec 14The Scotts Miracle-Gro Company, Annual General Meeting, Jan 22, 2024The Scotts Miracle-Gro Company, Annual General Meeting, Jan 22, 2024, at 09:00 US Eastern Standard Time. Agenda: To consider election of four directors, each to serve for a term of three years to expire at the 2027 annual meeting of shareholders; to consider approval on an advisory basis, of the compensation of the company's named executive officers; to consider ratification of selection of Deloitte & Touche LLP as the company's independent registered public for the fiscal year ending September 30, 2024; and to consider other matters.
New Risk • Nov 26New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.8x net interest cover). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.3% average weekly change). Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Significant insider selling over the past 3 months (US$4.4m sold).
お知らせ • Nov 17The Scotts Miracle-Gro Company Announces Executive ChangesOn September 27, 2023, The Scotts Miracle-Gro Company announced that Denise Stump, the Company’s former Executive Vice President, Global Human Resources and Chief Ethics Officer, would be departing the Company on October 1, 2023 (the “Termination Date”). On November 12, 2023, in connection with Ms. Stump’s departure, The Scotts Company LLC, a subsidiary of the Company (“Scotts LLC”), entered into a Separation Agreement and Release of All Claims (the “Separation Agreement”) with Ms. Stump. The Separation Agreement addresses the payments and benefits to which Ms. Stump is entitled in connection with her departure.
Upcoming Dividend • Nov 17Upcoming dividend of US$0.66 per share at 4.6% yieldEligible shareholders must have bought the stock before 24 November 2023. Payment date: 08 December 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 4.6%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (3.1%).
Recent Insider Transactions • Nov 07President recently sold US$4.3m worth of stockOn the 3rd of November, James Hagedorn sold around 81k shares on-market at roughly US$53.02 per share. This transaction amounted to 67% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by US$9.1m.
Reported Earnings • Nov 01Full year 2023 earnings released: US$6.79 loss per share (vs US$7.88 loss in FY 2022)Full year 2023 results: US$6.79 loss per share (improved from US$7.88 loss in FY 2022). Revenue: US$3.55b (down 9.5% from FY 2022). Net loss: US$380.1m (loss narrowed 13% from FY 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 01The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on December 8, 2023The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on December 8, 2023, to shareholders of record as of November 27, 2023.
お知らせ • Sep 28+ 1 more updateThe Scotts Miracle-Gro Company to Report Fiscal Year 2023 Results on Nov 01, 2023The Scotts Miracle-Gro Company announced that they will report fiscal year 2023 results on Nov 01, 2023
お知らせ • Aug 29The Scotts Miracle-Gro Company Announces Executive ChangesThe Scotts Miracle-Gro Company announced that it is executing a succession plan for President and COO Mike Lukemire in preparation for his retirement in fiscal 2024. Under the plan approved by the Board of Directors and agreed upon by Lukemire and Chairman and CEO Jim Hagedorn, Lukemire will step down as COO on September 3, 2023, and retain his position as president until his retirement. In a related move, Nate Baxter, 50, executive vice president of technology &operations, will be promoted to chief operating officer on September 4, 2023, reporting to Lukemire, who will mentor Baxter during a transition period. Lukemire, 65, has been with the Company for almost 28 years, serving as president since February 2016 and COO since January 2015. Baxter joined the Company on April 28, 2023, to oversee research and development, information technology, regulatory, quality and environmental health and safety. In his new role, he additionally will be responsible for supply chain, sales and marketing. He previously was president of TEL U.S., a Tokyo Electron Ltd. subsidiary that manufactures semiconductor and flat panel manufacturing equipment, where he led development, production, sales and marketing. He also worked with Intel Corporation in technology, supply chain, strategy and management. He has undergraduate and advanced degrees from Rollins College and Georgia Institute of Technology, respectively, and is a general partner of the Hagedorn Partnership, L.P.
Upcoming Dividend • Aug 17Upcoming dividend of US$0.66 per share at 5.3% yieldEligible shareholders must have bought the stock before 24 August 2023. Payment date: 08 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.3%. Lower than top quartile of British dividend payers (6.2%). Higher than average of industry peers (2.8%).
Recent Insider Transactions • Aug 08CEO & Chairman of the Board recently sold US$3.1m worth of stockOn the 7th of August, James Hagedorn sold around 55k shares on-market at roughly US$56.32 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by US$4.8m.
お知らせ • Aug 03The Scotts Miracle-Gro Company Provides Earnings Guidance for the Full Year 2023The Scotts Miracle-Gro Company provided earnings guidance for the full year 2023. For the period, the company expects total net sales to decline approximately 10% to 11% mainly driven by a net sales decline in the U.S. Consumer segment of 2% to 4% and a net sales decline of 30% to 35% in the Hawthorne segment. Additionally, operating income is expected to range from 7% to 7.5% of sales for the year.
Reported Earnings • Aug 03Third quarter 2023 earnings released: EPS: US$0.78 (vs US$8.01 loss in 3Q 2022)Third quarter 2023 results: EPS: US$0.78 (up from US$8.01 loss in 3Q 2022). Revenue: US$1.12b (down 5.7% from 3Q 2022). Net income: US$43.7m (up US$487.6m from 3Q 2022). Profit margin: 3.9% (up from net loss in 3Q 2022). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 02The Scotts Miracle-Gro Company Announces Quarterly Cash Dividend, Payable on September 8, 2023The Scotts Miracle-Gro Company announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on September 8, 2023, to shareholders of record as of August 25, 2023.
Buying Opportunity • Jul 29Now 20% undervaluedOver the last 90 days, the stock is up 5.8%. The fair value is estimated to be US$88.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Jul 23The Scotts Miracle-Gro Company to Report Q3, 2023 Results on Aug 02, 2023The Scotts Miracle-Gro Company announced that they will report Q3, 2023 results Pre-Market on Aug 02, 2023
お知らせ • Jul 15The Scotts Miracle-Gro Company Announces Board ChangesThe Scotts Miracle-Gro Company announced that Mark D. Kingdon has been named to its Board of Directors. Kingdon has held senior executive positions ranging from president and CEO to founder of companies in the consumer, technology and digital spaces, among others. He has experience in finance, marketing, branding, innovation, business transformation and emerging technologies with a track record of achieving groundbreaking results. Kingdon is founder of Quixotic Ventures, which invests in early stage consumer internet companies, and held board seats with TheRealReal.com, SAY Media Inc., Linden Lab and Organic Inc. as well as several nonprofits, such as Miami’s New World Symphony. He previously was CEO of Linden Lab (developer of Second Life - the early metaverse) and Organic Inc. He also was a managing partner at PwC, where he ran the retail and distribution industries consulting practice for the Americas. He holds an MBA from the Wharton School of Business, University of Pennsylvania, and a Bachelor of Arts in Economics from the University of California, Los Angeles. Kingdon succeeds Gerald Volas, who resigned from the Board.
Buying Opportunity • Jul 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 6.4%. The fair value is estimated to be US$88.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company became loss making.
